Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Acquired, non-amyloid related factor X deficiency: review of the literature.

Lee G, Duan-Porter W, Metjian AD.

Haemophilia. 2012 Sep;18(5):655-63. Review. No abstract available.

PMID:
23437437
3.

Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy.

Choufani EB, Sanchorawala V, Ernst T, Quillen K, Skinner M, Wright DG, Seldin DC.

Blood. 2001 Mar 15;97(6):1885-7.

4.

A case of acquired factor X deficiency with in vivo and in vitro evidence of inhibitor activity directed against factor X.

Mulhare PE, Tracy PB, Golden EA, Branda RF, Bovill EG.

Am J Clin Pathol. 1991 Aug;96(2):196-200.

PMID:
1862774
5.
6.

Normalization of plasma factor X levels in amyloidosis after plasma exchange.

Beardell FV, Varma M, Martinez J.

Am J Hematol. 1997 Jan;54(1):68-71.

7.
8.

Acquired factor X deficiency in light chain amyloidosis: a report of 2 Korean cases.

Ma Y, Kwon EH, Lee JE, Kim K, Kim HJ, Kim SH.

Korean J Lab Med. 2011 Jul;31(3):154-6. doi: 10.3343/kjlm.2011.31.3.154. Epub 2011 Jun 28.

9.

Successful perioperative management of factor X deficiency associated with primary amyloidosis.

Takabe K, Holman PR, Herbst KD, Glass CA, Bouvet M.

J Gastrointest Surg. 2004 Mar-Apr;8(3):358-62. Review.

PMID:
15019934
10.

Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis.

Enjeti AK, Walsh M, Seldon M.

Haemophilia. 2005 Sep;11(5):535-8.

PMID:
16128899
11.

[AL amyloidosis-associated factor X deficiency].

Croles FN, Beerenhout CH, Mulder AB, Meijer K, Nijziel MR.

Ned Tijdschr Geneeskd. 2014;158(6):A6678. Dutch.

PMID:
24495369
12.

[How can factor X deficiency in nephropathy explained?].

Alscher DM.

Dtsch Med Wochenschr. 2003 May 9;128(19):1072. German. No abstract available.

PMID:
12736861
13.

Refractory hematuria from amyloidosis successfully treated by splenectomy.

Ma JF, Coutre SE, Curet MJ, Brooks JD.

Urology. 2006 May;67(5):1085.e13-5.

PMID:
16698382
14.

Mechanism of factor X deficiency in systemic amyloidosis.

Furie B, Voo L, McAdam KP, Furie BC.

N Engl J Med. 1981 Apr 2;304(14):827-30. No abstract available.

PMID:
7207512
15.

Factor X deficiency in primary amyloidosis: resolution after splenectomy.

Greipp PR, Kyle RA, Bowie EJ.

N Engl J Med. 1979 Nov 8;301(19):1050-1. No abstract available.

PMID:
492235
16.

An acquired, calcium-dependent, factor X inhibitor.

Broze GJ Jr.

Blood Cells Mol Dis. 2014 Feb-Mar;52(2-3):116-20. doi: 10.1016/j.bcmd.2013.09.001. Epub 2013 Sep 26.

17.

Treatment of amyloidosis associated factor X deficiency.

Spero JA, Lewis JH, Hasiba U, Ellis LD.

Thromb Haemost. 1976 Apr 30;35(2):377-81.

PMID:
989637
18.

Factor X deficiency and systemic amyloidosis.

Glenner GG.

N Engl J Med. 1977 Jul 14;297(2):108-9. No abstract available.

PMID:
405589
19.

Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications.

Ashrani AA, Aysola A, Al-Khatib H, Nichols WL, Key NS.

Br J Haematol. 2003 May;121(4):639-42.

PMID:
12752106
20.

Resolution of acquired factor X deficiency with amyloidosis secondary to plasma cell dyscrasia.

Mohri H.

Am J Hematol. 2004 Dec;77(4):421-2. No abstract available.

Supplemental Content

Support Center